Table 3.
Characteristics of PCOS patients and controls
| PCOS (n = 10) | Control (n = 8) | P | |
|---|---|---|---|
| Age | 28.80 ± 3.97 | 32.00 ± 2.16 | 0.086 |
| BMI, kg/m2 | 24.42 ± 4.84 | 20.51 ± 2.06 | 0.051 |
| mFG score | 4.3 ± 4.74 | 0.43 ± 0.787 | 0.004 |
| TT, nmol/L | 2.47 ± 0.64 | 1.27 ± 0.60 | 0.005 |
| FT, pg/mL l | 3.99 ± 2.75 | 1.85 ± 0.62 | 0.025 |
| FIN, mU/L | 13.45 ± 7.25 | 4.52 ± 1.65 | 0.001 |
| FBG, mmol/L | 4.71 ± 0.44 | 4.24 ± 0.69 | 0.201 |
| HOMA-IR | 2.85 ± 1.70 | 0.86 ± 0.39 | 0.001 |
Values are expressed as mean ± standard deviation. P < 0.05 is considered statistically significant. PCOS: Polycystic ovary syndrome; BMI: Body mass index; mFG: Modified Ferriman–Gallwey; TT: Total testosterone; FT: Free testosterone; FIN: Fasting insulin; FBG: Fasting blood glucose; HOMA-IR: Homeostasis model assessment-insulin resistance.